179 related articles for article (PubMed ID: 27647805)
1. A novel, multiplexed targeted mass spectrometry assay for quantification of complement factor H (CFH) variants and CFH-related proteins 1-5 in human plasma.
Zhang P; Zhu M; Geng-Spyropoulos M; Shardell M; Gonzalez-Freire M; Gudnason V; Eiriksdottir G; Schaumberg D; Van Eyk JE; Ferrucci L; Semba RD
Proteomics; 2017 Mar; 17(6):. PubMed ID: 27647805
[TBL] [Abstract][Full Text] [Related]
2. Rapid and sensitive method for detection of Y402, H402, I62, and V62 variants of complement factor H in human plasma samples using mass spectrometry.
Kelly U; Rickman CB; Postel EA; Hauser MA; Hageman GS; Arshavsky VY; Skiba NP
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1540-5. PubMed ID: 19029036
[TBL] [Abstract][Full Text] [Related]
3. Bisretinoid-mediated complement activation on retinal pigment epithelial cells is dependent on complement factor H haplotype.
Radu RA; Hu J; Jiang Z; Bok D
J Biol Chem; 2014 Mar; 289(13):9113-20. PubMed ID: 24550392
[TBL] [Abstract][Full Text] [Related]
4. Protective chromosome 1q32 haplotypes mitigate risk for age-related macular degeneration associated with the CFH-CFHR5 and ARMS2/HTRA1 loci.
Pappas CM; Zouache MA; Matthews S; Faust CD; Hageman JL; Williams BL; Richards BT; Hageman GS
Hum Genomics; 2021 Sep; 15(1):60. PubMed ID: 34563268
[TBL] [Abstract][Full Text] [Related]
5. Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration.
Ansari M; McKeigue PM; Skerka C; Hayward C; Rudan I; Vitart V; Polasek O; Armbrecht AM; Yates JR; Vatavuk Z; Bencic G; Kolcic I; Oostra BA; Van Duijn CM; Campbell S; Stanton CM; Huffman J; Shu X; Khan JC; Shahid H; Harding SP; Bishop PN; Deary IJ; Moore AT; Dhillon B; Rudan P; Zipfel PF; Sim RB; Hastie ND; Campbell H; Wright AF
Hum Mol Genet; 2013 Dec; 22(23):4857-69. PubMed ID: 23873044
[TBL] [Abstract][Full Text] [Related]
6. Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration.
Lorés-Motta L; van Beek AE; Willems E; Zandstra J; van Mierlo G; Einhaus A; Mary JL; Stucki C; Bakker B; Hoyng CB; Fauser S; Clark SJ; de Jonge MI; Nogoceke E; Koertvely E; Jongerius I; Kuijpers TW; den Hollander AI
Am J Hum Genet; 2021 Aug; 108(8):1367-1384. PubMed ID: 34260947
[TBL] [Abstract][Full Text] [Related]
7. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.
Hageman GS; Hancox LS; Taiber AJ; Gehrs KM; Anderson DH; Johnson LV; Radeke MJ; Kavanagh D; Richards A; Atkinson J; Meri S; Bergeron J; Zernant J; Merriam J; Gold B; Allikmets R; Dean M;
Ann Med; 2006; 38(8):592-604. PubMed ID: 17438673
[TBL] [Abstract][Full Text] [Related]
8. Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice.
Landowski M; Kelly U; Klingeborn M; Groelle M; Ding JD; Grigsby D; Bowes Rickman C
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3703-3711. PubMed ID: 30808757
[TBL] [Abstract][Full Text] [Related]
9. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).
Fritsche LG; Lauer N; Hartmann A; Stippa S; Keilhauer CN; Oppermann M; Pandey MK; Köhl J; Zipfel PF; Weber BH; Skerka C
Hum Mol Genet; 2010 Dec; 19(23):4694-704. PubMed ID: 20843825
[TBL] [Abstract][Full Text] [Related]
10. Proteomic genotyping of SNP of Complement Factor H (CFH) Y402H and I62V using multiple reaction monitoring (MRM) assays.
Kim KL; Kim H; Lee Y; Lee C; Joo K; Park SJ; Park KH; Park SJ; Woo SJ
Sci Rep; 2022 Nov; 12(1):19587. PubMed ID: 36379987
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility.
Zhao J; Wu H; Khosravi M; Cui H; Qian X; Kelly JA; Kaufman KM; Langefeld CD; Williams AH; Comeau ME; Ziegler JT; Marion MC; Adler A; Glenn SB; Alarcón-Riquelme ME; ; ; Pons-Estel BA; Harley JB; Bae SC; Bang SY; Cho SK; Jacob CO; Vyse TJ; Niewold TB; Gaffney PM; Moser KL; Kimberly RP; Edberg JC; Brown EE; Alarcon GS; Petri MA; Ramsey-Goldman R; Vilá LM; Reveille JD; James JA; Gilkeson GS; Kamen DL; Freedman BI; Anaya JM; Merrill JT; Criswell LA; Scofield RH; Stevens AM; Guthridge JM; Chang DM; Song YW; Park JA; Lee EY; Boackle SA; Grossman JM; Hahn BH; Goodship TH; Cantor RM; Yu CY; Shen N; Tsao BP
PLoS Genet; 2011 May; 7(5):e1002079. PubMed ID: 21637784
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration.
Kelly U; Yu L; Kumar P; Ding JD; Jiang H; Hageman GS; Arshavsky VY; Frank MM; Hauser MA; Rickman CB
J Immunol; 2010 Nov; 185(9):5486-94. PubMed ID: 20876352
[TBL] [Abstract][Full Text] [Related]
13. A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes.
Alic L; Papac-Milicevic N; Czamara D; Rudnick RB; Ozsvar-Kozma M; Hartmann A; Gurbisz M; Hoermann G; Haslinger-Hutter S; Zipfel PF; Skerka C; Binder EB; Binder CJ
Proc Natl Acad Sci U S A; 2020 May; 117(18):9942-9951. PubMed ID: 32321835
[TBL] [Abstract][Full Text] [Related]
14. Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population.
Liu X; Zhao P; Tang S; Lu F; Hu J; Lei C; Yang X; Lin Y; Ma S; Yang J; Zhang D; Shi Y; Li T; Chen Y; Fan Y; Yang Z
Retina; 2010 Sep; 30(8):1177-84. PubMed ID: 20523265
[TBL] [Abstract][Full Text] [Related]
15. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration.
Wegscheider BJ; Weger M; Renner W; Steinbrugger I; März W; Mossböck G; Temmel W; El-Shabrawi Y; Schmut O; Jahrbacher R; Haas A
Ophthalmology; 2007 Apr; 114(4):738-42. PubMed ID: 17398321
[TBL] [Abstract][Full Text] [Related]
16. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration].
Kubicka-Trząska A; Karska-Basta I; Kobylarz J; Dziedzina S; Sanak M; Romanowska-Dixon B
Klin Oczna; 2016; 118(2):114-21. PubMed ID: 29912491
[TBL] [Abstract][Full Text] [Related]
17. Role of complement factor B rs4151667 (L9H) polymorphisms and its interactional role with CFH Y402H and C3 rs2230199 (R102G) risk variants in age-related macular degeneration: a case control study.
Roshanipour N; Laleh MG; Bonyadi M; Bonyadi MHJ; Soheilian M; Javadzadeh A; Yaseri M
BMC Ophthalmol; 2020 Aug; 20(1):323. PubMed ID: 32762675
[TBL] [Abstract][Full Text] [Related]
18. Biochemical analysis of a common human polymorphism associated with age-related macular degeneration.
Yu J; Wiita P; Kawaguchi R; Honda J; Jorgensen A; Zhang K; Fischetti VA; Sun H
Biochemistry; 2007 Jul; 46(28):8451-61. PubMed ID: 17580967
[TBL] [Abstract][Full Text] [Related]
19. Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration.
Martínez-Barricarte R; Recalde S; Fernández-Robredo P; Millán I; Olavarrieta L; Viñuela A; Pérez-Pérez J; García-Layana A; Rodríguez de Córdoba S;
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1087-94. PubMed ID: 22247456
[TBL] [Abstract][Full Text] [Related]
20. Copy number variation in the complement factor H-related genes and age-related macular degeneration.
Kubista KE; Tosakulwong N; Wu Y; Ryu E; Roeder JL; Hecker LA; Baratz KH; Brown WL; Edwards AO
Mol Vis; 2011; 17():2080-92. PubMed ID: 21850184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
